These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related]
4. [The microbiological faultlessness of drugs. III. Development and problems of testing methods]. Sagáth J; Chalabala M; Bábik I Cesk Farm; 1978 Oct; 27(8):353-8. PubMed ID: 743754 [No Abstract] [Full Text] [Related]
5. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
6. The Third Policy Arena: Standard-Setting Organizations. Consult Pharm; 2016 Mar; 31(3):176. PubMed ID: 26975597 [No Abstract] [Full Text] [Related]
7. GMPs vs GCPs: United States Pharmacopeia General Chapters. Allen LV Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791 [No Abstract] [Full Text] [Related]
8. Information chapters in pharmacopoeias. Banes D Ann Ist Super Sanita; 1975; 11(3-4):290-5. PubMed ID: 1234730 [TBL] [Abstract][Full Text] [Related]
9. Sterilization of compounded parenteral preparations: verification of autoclaves. Rahe H Int J Pharm Compd; 2013; 17(2):94-8. PubMed ID: 23696169 [TBL] [Abstract][Full Text] [Related]
10. PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives. Allen LV Int J Pharm Compd; 2017; 21(3):180. PubMed ID: 28557778 [No Abstract] [Full Text] [Related]
11. General requirements for parenteral pharmaceuticals for the 21st USP revision--for the 21st Century. Barnstein CH J Parenter Drug Assoc; 1979; 33(5):287-9. PubMed ID: 259651 [No Abstract] [Full Text] [Related]
12. [Pharmacopoeias and official quality standards for pharmaceutical evaluation in the Hungarian People's Republic]. Laszlovszky J Pharmazie; 1981 Nov; 36(11):778-9. PubMed ID: 7323127 [No Abstract] [Full Text] [Related]
13. Ingredients in pharmaceutical preparations: a problem not value. Lubner GC Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372 [No Abstract] [Full Text] [Related]
14. [Terminology of chemical compounds in the 3d edition of the Czechoslovakian Pharmacopeia]. Borovanský A; Palát K Cesk Farm; 1970 Dec; 19(10):370-3. PubMed ID: 5492520 [No Abstract] [Full Text] [Related]
16. Specifications for the quality control of pharmaceutical preparations. WHO Chron; 1967 Oct; 21(10):438-40. PubMed ID: 6060394 [No Abstract] [Full Text] [Related]
17. What is a good drug? Owen JA Hosp Formul; 1975 Mar; 10(3):108. PubMed ID: 10316675 [No Abstract] [Full Text] [Related]
18. The importance of drug standards. Heller WM Am J Hosp Pharm; 1982 Apr; 39(4):652-3. PubMed ID: 7081247 [No Abstract] [Full Text] [Related]
19. Drug standards--communication and revision. Barnstein CH J Parenter Drug Assoc; 1979; 33(5):237-8. PubMed ID: 259643 [No Abstract] [Full Text] [Related]
20. Content uniformity and assay requirements in current regulations. Bánfai B; Ganzler K; Kemény S J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]